What is Viridian Therapeutics, Inc.'s net investment in lease?

Viridian Therapeutics, Inc. (VRDN) reported net investment in lease of $2.26M in Q1 2026.

How has Viridian Therapeutics, Inc.'s net investment in lease changed year-over-year?

Viridian Therapeutics, Inc.'s net investment in lease increased by 7.8% year-over-year, from $2.09M to $2.26M.

What is the long-term trend for Viridian Therapeutics, Inc.'s net investment in lease?

Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s net investment in lease has grown at a 89.1% compound annual growth rate (CAGR), from $100K to $2.42M.

Viridian Therapeutics, Inc. VRDN Net Investment in Lease

Net Investment in Lease at other companies

Vir Biotechnology, Inc.VIR

——

Syndax PharmaceuticalsSNDX

——

PVL

Palvella TherapeuticsPVLA

——

TG TherapeuticsTGTX

——

Krystal Biotech, Inc.KRYS

——

Arrowhead ResearchARWR

——

Other financials

Income statement

See full

Revenue$141.0K+95.8%

Operating income-$116.2M-23.8%

Net income-$104.9M-20.7%

EPS (diluted)-$1.15-5.5%

Balance sheet

See full

Cash & equivalents$176.3M+51.7%

Total debt$36.8M+59.4%

Total equity$636.0M+5.2%

Total assets$789.0M+19.4%

Cash flow

See full

Operating cash flow-$119.7M-29.1%

CapEx$23.0K-73.3%

Free cash flow-$119.7M-29.0%

Valuation

See full

Market cap$1.91B+82.0%

Enterprise value$1.77B+85.0%

P/S26.9×-3,445×

Profitability

See full

Gross margin36.3%—

Operating margin-543.9%-271pp

Net margin-508.5%-254pp

FCF margin-428.4%-214pp

Returns & leverage

See full

Return on equity-58.1%+7.9pp

Debt / equity0.1×0.0×

Current ratio15.1×-4.3×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s net investment in lease?: Viridian Therapeutics, Inc. (VRDN) reported net investment in lease of $2.26M in Q1 2026.
How has Viridian Therapeutics, Inc.'s net investment in lease changed year-over-year?: Viridian Therapeutics, Inc.'s net investment in lease increased by 7.8% year-over-year, from $2.09M to $2.26M.
What is the long-term trend for Viridian Therapeutics, Inc.'s net investment in lease?: Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s net investment in lease has grown at a 89.1% compound annual growth rate (CAGR), from $100K to $2.42M.